About Osmifen 60 mg Tablet
Osmifen 60 mg tablet is a prescription medicine containing ospemifene. It is used in postmenopausal women for moderate to severe pain during sex and vaginal dryness caused by vulvar and vaginal atrophy.
What is Osmifen 60 mg Tablet?
Osmifen is a tablet containing 60 mg of ospemifene. It belongs to a group of medicines that act on estrogen receptors in different tissues. It is used in women after menopause for moderate to severe dyspareunia (pain during sexual intercourse) and moderate to severe vaginal dryness, both symptoms of vulvar and vaginal atrophy. The medicine is available in a pack of 3 x 10 tablets. It is a prescription-only medicine, so the doctor will decide if it is suitable and how long it should be used.
Uses of Osmifen
Osmifen is used to treat moderate to severe pain during sexual intercourse and moderate to severe vaginal dryness in postmenopausal women. These symptoms are part of vulvar and vaginal atrophy due to menopause. The medicine works on estrogen receptors and may help relieve these symptoms. Only a doctor can confirm whether your symptoms are due to this condition and whether this medicine is appropriate for you.
How to use Osmifen
Take Osmifen exactly as your doctor prescribes. The tablet is usually taken with food. The doctor will decide the dose and how long you should take it, based on your needs and risks. Do not change the dose or stop the medicine without talking to your doctor. If you miss a dose, ask your doctor or pharmacist what to do. Swallow the tablet with water unless your doctor advises otherwise.
Side effects of Osmifen
Like all medicines, Osmifen can cause side effects. Commonly reported ones include hot flushes, vaginal discharge, muscle spasms, headache, excessive sweating, vaginal bleeding and night sweats. Some side effects may be serious. Tell your doctor promptly if you have unusual vaginal bleeding, leg pain or swelling, shortness of breath, chest pain, or signs of an allergic reaction such as rash, itching or swelling. Your doctor can advise you on what to do.
Safety and precautions
Osmifen should not be used by women who are pregnant or may become pregnant, or who are breastfeeding. It is also not for women with undiagnosed abnormal genital bleeding, known or suspected estrogen-dependent cancer, a history of blood clots in the veins or lungs, or a history of stroke or heart attack. Tell your doctor if you have breast cancer, liver problems, or a history of blood clots. The doctor will decide if it is safe for you and will review your treatment regularly.
Frequently asked questions
What is the price of Osmifen?
The listed price is ৳ 30.00. Prices can vary, so check with your pharmacy for the current price. The pack contains 3 x 10 tablets.
What does the generic name ospemifene mean?
Ospemifene is the generic name of the active ingredient. It is a type of medicine that acts on estrogen receptors in the body. Osmifen is a brand name for this medicine made by Nuvista Pharma Ltd.
What is Osmifen used for and what kind of medicine is it?
Osmifen is used in postmenopausal women for moderate to severe pain during sex and vaginal dryness due to vulvar and vaginal atrophy. It is a tablet that acts on estrogen receptors. It is a prescription medicine, so your doctor will decide if it is right for you.
Who should avoid Osmifen or ask the doctor first?
Do not use it if you are pregnant, may become pregnant, or are breastfeeding. Avoid it if you have undiagnosed vaginal bleeding, known or suspected estrogen-dependent cancer, or a history of blood clots, stroke or heart attack. Ask your doctor first if you have breast cancer, liver problems, or a history of these conditions.
- Strength
- 60 mg
Price in Bangladesh
৳ 29.4 ৳ 30.00 2% off unit price
Price updated: 18 Nov 2026
Indications
Ospemifene is indicated for:
- The Treatment of Moderate to Severe Dyspareunia, a Symptom of Vulvar and Vaginal Atrophy, Due to Menopause.
- The Treatment of Moderate to Severe Vaginal Dryness, a Symptom of Vulvar and Vaginal Atrophy, Due to Menopause.
Pharmacology
Ospemifene is an estrogen receptor agonist/antagonist with tissue selective effects. Its biological actions are mediated through binding to estrogen receptors. This binding results in activation of estrogenic pathways in some tissues (agonism) and blockade of estrogenic pathways in others (antagonism).
Dosage & Administration
Ospemifene is an estrogen agonist/antagonist which has agonistic effects on the endometrium. Use of Ospemifene should be for the shortest duration consistent with treatment goals and risks for the individual woman. Postmenopausal women should be re-evaluated periodically as clinically appropriate to determine if treatment is still necessary.
- Treatment of Moderate to Severe Dyspareunia, a Symptom of Vulvar and Vaginal Atrophy, Due to Menopause: Take one 60 mg tablet with food once daily.
- Treatment of Moderate to Severe Vaginal Dryness, a Symptom of Vulvar and Vaginal Atrophy, Due to Menopause: Take one 60 mg tablet with food once daily.
Interaction
- Do not use estrogens or estrogen agonist/antagonist concomitantly with Ospemifene.
- Do not use fluconazole concomitantly with Ospemifene. Fluconazole increases serum concentrations of Ospemifene.
- Do not use rifampin concomitantly with Ospemifene. Rifampin decreases serum concentration of Ospemifene.
Contraindications
Ospemifene is contraindicated in women with any of the following conditions:
- Undiagnosed abnormal genital bleeding
- Known or suspected estrogen-dependent neoplasia
- Active DVT, pulmonary embolism (PE), or a history of these conditions
- Active arterial thromboembolic disease [for example, stroke and myocardial infarction (MI)], or a history of these conditions
- Hypersensitivity (for example, angioedema, urticaria, rash, pruritus) to Ospemifene or any ingredients
- Ospemifene is contraindicated in women who are or may become pregnant. Ospemifene may cause fetal harm when administered to a pregnant woman. Ospemifene was embryo-fetal lethal with labor difficulties and increased pup deaths in rats at doses below clinical exposures, and embryo-fetal lethal in rabbits at 10 times the clinical exposure based on mg/m 2 . If this drug is used during pregnancy, or if a woman becomes pregnant while taking this drug, she should be apprised of the potential hazard to a fetus.
Side Effects
Adverse reactions (≥1 percent) include hot flush, vaginal discharge, muscle spasms, headache, hyperhidrosis, vaginal hemorrhage, night sweats.
Pregnancy & Lactation
Pregnancy: Ospemifene is contraindicated in women who are or may become pregnant. If this drug is used during pregnancy, or if a woman becomes pregnant while taking this drug, she should be apprised of the potential hazard to a fetus. Based on animal data, Ospemifene is likely to increase the risk of adverse outcomes during pregnancy and labor. Adverse findings at maternally toxic doses included embryofetal lethality in rats and rabbits, and neonatal mortality and difficult labor in rats. The reproductive effects observed are consistent with and are considered to be related to the estrogen receptor activity of Ospemifene.
Lactation: It is not known whether Ospemifene is excreted in human breast milk. There are no data on the effects of Ospemifene on the breastfed child or the effects on milk production. Do not breastfeed while taking Ospemifene. Ospemifene was excreted in rat milk
Precautions & Warnings
- Venous Thromboembolism: Risk of DVT and pulmonary embolism
- Known, suspected, or history of breast cancer
- Severe Hepatic Impairment
Storage Conditions
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.